home / stock / xgn / xgn news

XGN News and Press, Exagen Inc. From 02/03/21

Stock Information
Company Name: Exagen Inc.
Stock Symbol: XGN
Market: NYSE
Website: exagen.com
Menu
XGN XGN Quote XGN Short XGN News XGN Articles XGN Message Board
Get XGN Alerts

News, Short Squeeze, Breakout and More Instantly...
XGN - Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading autoimmune organization, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 17-19, 2021. Ron Rocca, Exag...
XGN - SWIR, PGEN, GSL and FLDM among after-hours movers

Gainers: [[TGC]] +29.7%. [[FLDM]] +17.7%. [[SWIR]] +13%. [[XGN]] +12%.  [[RNWK]] +6.8%.Losers: [[PGEN]] -8.3%. [[USX]] -7.9%. [[GSL]] -7.4%. [[CTK]] -7%. [[RUHN]] -6.4%. For further details see: SWIR, PGEN, GSL and FLDM among after-hours movers

XGN - Exagen teams up with Tufts Medical Center for its AVISE tests

Exagen (XGN) announces that all of its AVISE test offerings are now a contracted in-network service with Tufts Medical Center, an internationally-respected academic medical center."The incorporation of AVISE testing will play an important part in enabling rheumatologists’ ability to im...

XGN - Exagen Inc. Partners with Boston's Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that all AVISE test offerings (CTD, Lupus, SLE Prognostic, SLE Monitor, APS, Vascul...
XGN - Exagen issues preliminary testing revenue ahead of ICT chat

Exagen (XGN) moves up 1.98% after the autoimmune-related healthcare services company posts preliminary figures for FQ4 yesterday. Testing revenue to be $10.5-$10.8M (+10% to +13% Y/Y).However, the company holds back its SIMPONI revenue estimate due to the nature ...

XGN - Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results

Record Testing Revenue, Adopters and AVISE CTD ® Volumes SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported preliminary...

XGN - Exagen Inc. To Participate in 2021 ICR Conference

SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the 2021 ICR Conference, which takes pl...
XGN - Exagen Inc. Partners with Oregon's St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that all AVISE test offerings (CTD, Lupus, SLE Prognostic, SLE Monitor, APS, Vascul...

XGN - UUU, ACY, IRIX, and ARCT among after-hours movers

Gainers: [[UUU]] +71.2%. [[IRIX]] +28.6%. [[XGN]] +10.6%. [[CANG]] +10.5%. [[MIRM]] +6.4%.Losers: [[ARCT]] -35.3%. [[ACY]] -23.3%. [[AIRT]] -8.8%. [[RHE]] -7.6%. [[RCMT]] -6.2%. For further details see: UUU, ACY, IRIX, and ARCT among after-hours movers

XGN - Exagen (XGN) Investor Presentation - Slideshow

The following slide deck was published by Exagen Inc. in conjunction with this event. For further details see: Exagen (XGN) Investor Presentation - Slideshow

Previous 10 Next 10